ACS Applied Materials & Interfaces · 2019 · 49 citations · 51 references
Natural SciencesBioengineeringOncologyBiomaterialsDrug DeliveryNanomaterialsCancer NanomedicineGelsHydrogelsNanomaterials For Drug DeliveryNanomedicinePhotothermal TherapyCancer NanotherapyCancer Photothermal TherapyHydrogel MaterialsHyperthermiaPhotothermal EffectsPhotothermal RegulationTumor RetentionTumor-targeted Drug Delivery
Complete tumor regression is a great challenge faced by single therapy of near-infrared (NIR)-triggered hyperthermia or vascular disrupting agents. An injectable nanocomposite (NC) hydrogel is rationally designed for combined anticancer therapy based on NIR-triggered hyperthermia and vascular disruption. The NC hydrogel, codelivered with Prussian blue (PB) nanoparticles and combretastatin A4 (CA4), has good shear-thinning, self-recovery, and excellent photothermal properties. Because of the remarkable tumor-site retention and sustained release of CA4 (about 10% over 12 days), the NC hydrogel has a tumor suppression rate of 99.6%. The programmed combinational therapy conveys the concept of "attack + guard", where PB-based NIR irradiation imposes intensive attack on most of cancer cells, and CA4 serves as a guard against the tumor growth by cutting off the energy supply. Moreover, the biosafety and eco-friendliness of the hydrogel platform pave the way toward clinical applications.
51
In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment
Qian Chen, Chao Wang, Xudong Zhang et al. · Nature Nanotechnology · 2018 · 1K citations
Medicine, Immunology, Oncology +10
Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system
Shiladitya Sengupta, David A. Eavarone, Ishan Capila et al. · Nature · 2005 · 943 citations
Pharmacy, Oncology, Pharmaceutics +16
Therapy-Induced Acute Recruitment of Circulating Endothelial Progenitor Cells to Tumors
Yuval Shaked, Alessia Ciarrocchi, Marcela Franco et al. · Science · 2006 · 568 citations
Medicine, Cancer Biology, Oncology +17